Reason: Follow up chronic pancreatitis, rule out new necrotic areas. History: h/o abd pain with chronic pancreatitis ABDOMEN:LIVER, BILIARY TRACT: Stable appearance of fatty liver. No intra-or extrahepatic biliary ductal dilatation. No cholelithiasis or choledocholithiasis. Common bile duct is non-dilated measuring 6 mm and terminates in the second portion of the duodenum.SPLEEN: No significant abnormality noted.PANCREAS: The pancreatic duct is irregular and beaded with innumerable mildly dilated sidebranches. The main pancreatic duct is dilated measuring up to 6 mm. After secretin administration, there is no significant increase in the size of the pancreatic duct. However, there is increased fluid signal in the duodenum after secretin administration. Uniform enhancement of the pancreatic parenchyma. No peripancreatic fluid collection.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Subcentimeter right upper pole renal cyst. There is symmetric enhancement of the renal parenchyma.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTRY: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1. Dilated, irregular, and beaded appearance of the pancreatic duct with mildly dilated sidebranches. The diseased pancreatic duct did not significantly respond to secretin administration, but there was increased fluid in the duodenum with secretin administration suggestive of responsive exocrine function.2. Normal appearing common bile duct. No cholelithiasis or choledocholithiasis.